• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CIP2A 在口腔癌和异型增生中的表达和定位。

CIP2A expression and localization in oral carcinoma and dysplasia.

机构信息

Department of Oral Maxillofacial Surgery and Diagnostic Sciences, University of Florida, College of Dentistry, FL, USA.

出版信息

Cancer Biol Ther. 2010 Oct 1;10(7):694-9. doi: 10.4161/cbt.10.7.12895.

DOI:10.4161/cbt.10.7.12895
PMID:21068540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3230513/
Abstract

AIMS

Oral squamous cell carcinoma (OSCC) is the most prevalent malignancy of the oral cavity resulting in severe morbidity and mortality. To date only few proteins have been suggested as potential biomarkers or targets for this type of cancer. Cancerous inhibitor of PP2A (CIP2A) is a protein expressed in epithelial tissues that stabilizes the oncogene c-Myc and causes cell transformation. This study was designed to investigate the expression of CIP2A in OSCC cell lines and tissues representing human normal, dysplasia and OSCC.

METHODS

Using quantitative real time PCR, mRNA quantification for CIP2A was performed in a primary gingival cell line and OSCCs CAL 27 and SCC-25. Paraffin embedded human specimen classified as normal, dysplastic or OSCC were immunohistochemically stained for CIP2A expression. EGFR and CIP2A were also stained by immunofluorescence for co-localization. Samples of human normal oral tissue and OSCC were studied by PCR for mRNA expression of CIP2A.

RESULTS

CIP2A was significantly increased in the human carcinoma cell lines compared to the primary gingival cell line. CIP2A was overexpressed in the human oral dysplasia and OSCC tissues compared to normal oral tissues. CIP2A was also preferentially localized in the dysplastic and OSCC epithelial areas compared to EGFR that was expressed mainly in areas of relatively normal epithelium and in dysplastic tissues above the basal layers.

CONCLUSIONS

CIP2A may play a significant role in oral malignant transformation and therefore, it may be a potential target for chemotherapy of OSCC.

摘要

目的

口腔鳞状细胞癌(OSCC)是口腔最常见的恶性肿瘤,导致严重的发病率和死亡率。迄今为止,只有少数几种蛋白质被认为是这种癌症的潜在生物标志物或靶点。蛋白磷酸酶 2A 的致癌抑制剂(CIP2A)是一种在上皮组织中表达的蛋白质,它稳定致癌基因 c-Myc 并导致细胞转化。本研究旨在研究 CIP2A 在代表人类正常、发育不良和 OSCC 的 OSCC 细胞系和组织中的表达。

方法

使用定量实时 PCR,在原代牙龈细胞系和 OSCC 细胞 CAL 27 和 SCC-25 中进行 CIP2A 的 mRNA 定量。对石蜡包埋的人类标本进行 CIP2A 表达的免疫组织化学染色,这些标本分为正常、发育不良或 OSCC。还通过免疫荧光对 EGFR 和 CIP2A 进行共定位染色。通过 PCR 研究人正常口腔组织和 OSCC 样本中 CIP2A 的 mRNA 表达。

结果

与原代牙龈细胞系相比,CIP2A 在人类癌细胞系中显著增加。与正常口腔组织相比,CIP2A 在人类口腔发育不良和 OSCC 组织中过度表达。与主要在相对正常上皮区域和发育不良组织的基底层以上表达的 EGFR 相比,CIP2A 也优先定位于发育不良和 OSCC 上皮区域。

结论

CIP2A 可能在口腔恶性转化中发挥重要作用,因此,它可能是 OSCC 化疗的潜在靶点。

相似文献

1
CIP2A expression and localization in oral carcinoma and dysplasia.CIP2A 在口腔癌和异型增生中的表达和定位。
Cancer Biol Ther. 2010 Oct 1;10(7):694-9. doi: 10.4161/cbt.10.7.12895.
2
The role of CIP2A in oral squamous cell carcinoma.CIP2A在口腔鳞状细胞癌中的作用。
Cancer Biol Ther. 2010 Oct 1;10(7):700-2. doi: 10.4161/cbt.10.7.13151.
3
Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions.抑癌 miR-375 通过多个 miRNA-mRNA 相互作用抑制 CIP2A 编码序列来调节 MYC 表达。
Mol Biol Cell. 2013 Jun;24(11):1638-48, S1-7. doi: 10.1091/mbc.E12-12-0891. Epub 2013 Apr 3.
4
CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis.CIP2A 在非小细胞肺癌中过表达,并与不良预后相关。
Ann Surg Oncol. 2011 Mar;18(3):857-65. doi: 10.1245/s10434-010-1313-8. Epub 2010 Sep 15.
5
The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.E-钙黏蛋白下调在口腔癌中的作用:CDH1基因表达与表观遗传阻断
Curr Cancer Drug Targets. 2014;14(2):115-27. doi: 10.2174/1568009613666131126115012.
6
CIP2A cooperates with H-Ras to promote epithelial-mesenchymal transition in cervical-cancer progression.CIP2A 与 H-Ras 合作促进宫颈癌进展中的上皮-间质转化。
Cancer Lett. 2015 Jan 28;356(2 Pt B):646-55. doi: 10.1016/j.canlet.2014.10.013. Epub 2014 Oct 16.
7
Expression of FAP in Oral Leukoplakia and Oral Squamous Cell Carcinoma.FAP 在口腔白斑病和口腔鳞状细胞癌中的表达。
Int Dent J. 2024 Jun;74(3):581-588. doi: 10.1016/j.identj.2023.12.011. Epub 2024 Jan 26.
8
LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation.LDOC1因香烟暴露而沉默,并参与口腔肿瘤转化。
Oncotarget. 2015 Sep 22;6(28):25188-201. doi: 10.18632/oncotarget.4512.
9
Overexpression of T-type calcium channel Cav3.1 in oral squamous cell carcinoma: association with proliferation and anti-apoptotic activity.T 型钙通道 Cav3.1 在口腔鳞状细胞癌中的过表达:与增殖和抗凋亡活性的关联。
J Mol Histol. 2021 Jun;52(3):511-520. doi: 10.1007/s10735-020-09937-x. Epub 2021 Jan 4.
10
Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.甲状旁腺激素相关蛋白作为口腔鳞状细胞癌的预后指标。
J Exp Clin Cancer Res. 2014 Dec 18;33(1):100. doi: 10.1186/s13046-014-0100-y.

引用本文的文献

1
Sensitive Detection of Oral Leukoplakia: Analyzing P90 Biomarkers in Saliva and Tissue.口腔白斑病的敏感检测:分析唾液和组织中的 P90 生物标志物。
Biosensors (Basel). 2024 May 30;14(6):281. doi: 10.3390/bios14060281.
2
TIPRL1 and its ATM-dependent phosphorylation promote radiotherapy resistance in head and neck cancer.TIPRL1 及其 ATM 依赖性磷酸化促进头颈部癌症的放疗抵抗。
Cell Oncol (Dordr). 2024 Jun;47(3):793-818. doi: 10.1007/s13402-023-00895-6. Epub 2023 Nov 16.
3
High sensitivity CIP2A detection for oral cancer using a rapid transistor-based biosensor module.使用基于晶体管的快速生物传感器模块对口腔癌进行高灵敏度CIP2A检测。
J Vac Sci Technol B Nanotechnol Microelectron. 2023 Jan;41(1):013201. doi: 10.1116/6.0002175. Epub 2022 Dec 13.
4
Prognostic significance of pre-treatment serum Cyfra21-1 as a tumor marker in patients with oropharyngeal squamous cell carcinoma treated with concurrent chemoradiotherapy.治疗前血清细胞角蛋白19片段(Cyfra21-1)作为肿瘤标志物在接受同步放化疗的口咽鳞状细胞癌患者中的预后意义。
Ann Transl Med. 2020 Oct;8(20):1302. doi: 10.21037/atm-20-6124.
5
The Significance of the Dysregulation of Canonical Wnt Signaling in Head and Neck Squamous Cell Carcinomas.经典 Wnt 信号通路失调在头颈部鳞状细胞癌中的意义。
Cells. 2020 Mar 15;9(3):723. doi: 10.3390/cells9030723.
6
CIP2A overexpression in Taiwanese oral cancer patients.CIP2A在台湾口腔癌患者中的过表达。
Cancer Manag Res. 2019 Apr 5;11:2589-2594. doi: 10.2147/CMAR.S201154. eCollection 2019.
7
miR-548b-3p Regulates Proliferation, Apoptosis, and Mitochondrial Function by Targeting CIP2A in Hepatocellular Carcinoma.miR-548b-3p 通过靶向 CIP2A 调控肝癌细胞的增殖、凋亡和线粒体功能。
Biomed Res Int. 2018 Dec 23;2018:7385426. doi: 10.1155/2018/7385426. eCollection 2018.
8
Diagnostic values of serum tumor markers Cyfra21-1, SCCAg, ferritin, CEA, CA19-9, and AFP in oral/oropharyngeal squamous cell carcinoma.血清肿瘤标志物细胞角蛋白19片段(Cyfra21-1)、鳞状细胞癌抗原(SCCAg)、铁蛋白、癌胚抗原(CEA)、糖类抗原19-9(CA19-9)及甲胎蛋白(AFP)在口腔/口咽鳞状细胞癌中的诊断价值
Onco Targets Ther. 2016 Jun 3;9:3381-6. doi: 10.2147/OTT.S105672. eCollection 2016.
9
Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo.融合性寡聚精氨酸肽介导的CIP2A癌基因沉默在体内抑制口腔癌肿瘤生长。
J Control Release. 2015 Nov 28;218:72-81. doi: 10.1016/j.jconrel.2015.09.026. Epub 2015 Sep 18.
10
Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy.蛋白磷酸酶2A的癌性抑制剂(CIP2A)是结直肠癌肝转移切除术后野生型KRAS转移性结直肠癌的独立预后标志物。
BMC Cancer. 2015 Apr 17;15:301. doi: 10.1186/s12885-015-1300-3.

本文引用的文献

1
Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer.表皮生长因子受体靶向治疗 III 期和 IV 期头颈部癌症。
Curr Oncol. 2010 Jun;17(3):37-48. doi: 10.3747/co.v17i3.520.
2
Pragmatics versus contrarians: how does one resolve their differences with respect to oral cancer screening?实用主义者与反对者:在口腔癌筛查方面,人们如何解决他们之间的分歧?
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Mar;109(3):325-6. doi: 10.1016/j.tripleo.2009.12.022.
3
CIP2A is associated with human breast cancer aggressivity.CIP2A与人类乳腺癌侵袭性相关。
Clin Cancer Res. 2009 Aug 15;15(16):5092-100. doi: 10.1158/1078-0432.CCR-08-3283. Epub 2009 Aug 11.
4
Cancer statistics, 2009.2009年癌症统计数据。
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
5
MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.CIP2A在胃癌中的MYC依赖性调控及预后作用
J Natl Cancer Inst. 2009 Jun 3;101(11):793-805. doi: 10.1093/jnci/djp103. Epub 2009 May 26.
6
Diagnostic aids in the screening of oral cancer.口腔癌筛查中的诊断辅助手段。
Head Neck Oncol. 2009 Jan 30;1:5. doi: 10.1186/1758-3284-1-5.
7
Surveillance for cancers associated with tobacco use--United States, 1999-2004.美国1999 - 2004年与烟草使用相关癌症的监测
MMWR Surveill Summ. 2008 Sep 5;57(8):1-33.
8
CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells.CIP2A在胃癌中过表达,其缺失会导致肿瘤细胞的克隆形成能力受损、衰老或分化。
Clin Cancer Res. 2008 Jun 15;14(12):3722-8. doi: 10.1158/1078-0432.CCR-07-4137.
9
Multiple pathways regulated by the tumor suppressor PP2A in transformation.肿瘤抑制因子PP2A在细胞转化中调控的多种途径。
Trends Mol Med. 2008 Apr;14(4):152-60. doi: 10.1016/j.molmed.2008.02.001. Epub 2008 Mar 10.
10
Mechanisms of MYC stabilization in human malignancies.MYC在人类恶性肿瘤中稳定化的机制。
Cell Cycle. 2008 Mar 1;7(5):592-6. doi: 10.4161/cc.7.5.5492. Epub 2007 Dec 29.